首站-论文投稿智能助手
典型文献
DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling
文献摘要:
The outcome of pancreatic adenocarcinoma(PAAD)patients is poor,given resistance to gemcitabine.Long non-coding RNA(IncRNA)has been implicated in the carcinogenesis of pancreatic cancer;however,its function and mechanism in PAAD resistance to gemcitabine(GEM)are yet unknown.Herein,we demonstrate that IncRNA DSCR9 is significantly reduced in PAAD in vitro and in vivo.CCK-8,BrdU and flow cytometry assays show that overexpression of DSCR9 markedly suppresses pancreatic cancer cell proliferation and invasion,and promotes apoptosis under gemcitabine treatment.BTG2 acts as a tumor suppressor by reducing the proliferation and inva-sion of pancreatic cancer cells and increasing gemcitabine-induced apoptosis.Immunofluorescence(IF)staining combined with fluorescence in situ hybridization(FISH)of pancreatic cancer tissues shows that DSCR9 and BTG2 are both increased in pancreatic cancer tissues.Luciferase assay shows that miR-21-5p simultaneously binds to DSCR9 and 3'UTR of BTG2;DSCR9 relieves miR-21-5p-induced inhibition of BTG2 by competing with BTG2 for miR-21-5p binding.Overexpression of miR-21-5p enhances the invasiveness of pancreatic cancer cells by promoting cancer cell proliferation and invasion and attenuating gemcitabine-induced apoptosis.Overexpression of miR-21-5p attenuates the effect of DSCR9 overexpression on BTG2 expression and invasiveness of pancreatic cancer cells.Finally,miR-21-5p expression is increased,while BTG2 expression is decreased in pancreatic cancer tissues.miR-21-5p is negatively correlated with DSCR9 and BTG2.In conclusion,the DSCR9/miR-21-5p/BTG2 axis modulates pancreatic cancer proliferation,invasion,and gemcitabine resistance.
文献关键词:
作者姓名:
Hui Huang;Xia Li;Xianlin Zhang;Zhiqiang Li;Duo Han;Wenzhe Gao;Ling Liu;Cheng Peng;Hongwei Zhu;Xiao Yu
作者机构:
Department of Hepatopancreatobiliary Surgery,Third Xiangya Hospital,Central South University,Changsha 410013,China;Department of Endocrinology,Third Xiangya Hospital,Central South University,Changsha 410013,China;Department of General Surgery,Affiliated Renhe Hospital of China Three Gorges University,Yichang 443001,China;Department of Cardiology,Second People's Hospital of Hunan Province,Hunan University of Chinese Medicine,Changsha 410007,China
引用格式:
[1]Hui Huang;Xia Li;Xianlin Zhang;Zhiqiang Li;Duo Han;Wenzhe Gao;Ling Liu;Cheng Peng;Hongwei Zhu;Xiao Yu-.DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling)[J].生物化学与生物物理学报(英文版),2022(12):1775-1788
A类:
DSCR9
B类:
miR,5p,axis,inhibits,pancreatic,cancer,proliferation,resistance,gemcitabine,via,BTG2,signaling,outcome,adenocarcinoma,PAAD,patients,poor,given,Long,coding,IncRNA,has,been,implicated,carcinogenesis,however,function,mechanism,GEM,are,yet,unknown,Herein,demonstrate,that,significantly,reduced,vitro,vivo,CCK,BrdU,flow,cytometry,assays,overexpression,markedly,suppresses,invasion,promotes,apoptosis,under,treatment,acts,tumor,suppressor,by,reducing,cells,increasing,induced,Immunofluorescence,IF,staining,combined,situ,hybridization,FISH,tissues,shows,both,increased,Luciferase,simultaneously,binds,UTR,relieves,inhibition,competing,binding,Overexpression,enhances,invasiveness,promoting,attenuating,attenuates,effect,Finally,while,decreased,negatively,correlated,conclusion,modulates
AB值:
0.402696
相似文献
CircRNA.0007127 triggers apoptosis through the miR-513a-5p/CASP8 axis in K-562 cells
Xiajing LI;Yiyu ZHANG;Ning WANG;Zhaohu YUAN;Xiaojie CHEN;Qicong CHEN;Hui DENG;Xinxin TONG;Honglin CHEN;Yuyou DUAN;Yarning WEI-School of Medicine,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,Shenzhen Longhua Central Hospital,Shenzhen 518000,China;Laboratory of Stem Cells and Translational Medicine,Institutes for Life Sciences,School of Medicine,South China University of Technology,Guangzhou 510000,China;School of Biomedical Sciences and Engineering,Guangzhou International Campus,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,the Second Affiliation Hospital of South China University of Technology,Guangzhou 510000,China;Guangdong Engineering Research Center of Precise Transfusion,Guangzhou 510000,China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Fuzheng Kang'ai decoction(扶正抗癌方)inhibits cell proliferation,migration and invasion by modulating mir-21-5p/human phosphatase and tensin homology deleted on chromosome ten in lung cancer cells
LI Jinhua;LIU Chunping;ZHAO Yueyang;WU Wanyin;SUN Pengtao;LI Longmei;YANG Xiaobing;ZHOU Yushu-Department of Ultrasound,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Ultrasound,Institute of Ultrasound in Musculoskeletal Sports Medicine,Guangdong Second Provincial General Hospital,Guangzhou 510317,China;State Key Laboratory of Dampness Syndrome of Chinese Medicine,Guangdong Provincial Hospital of Chinese Medicine,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Hematology,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Oncology,Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma
Xiao Mo;Cheng-fei Zhang;Ping Xu;Min Ding;Zhi-jie Ma;Qi Sun;Yu Liu;Hong-kai Bi;Xin Guo;Alaa Abdelatty;Chao Hu;Hao-jun Xu;Guo-ren Zhou;Yu-liang Jia;Hong-ping Xia-Sir Run Run Hospital,Nanjing Medical University,Nanjing 211166,China;School of Basic Medical Sciences&State Key Laboratory of Reproductive Medicine&Key Laboratory of Antibody Technique of National Health Commission&Jiangsu Antibody Drug Engineering Research Center,Nanjing Medical University,Nanjing 210092,China;Jiangsu Cancer Hospital&Jiangsu Institute of Cancer Research&The Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210092,China;Yijishan Hospital of Wannan Medical College,Wannan Medical College,Wuhu 241002,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。